StemCART updates on achieved milestones on the way to phase 1 study
Cline Scientific AB (publ) ("Cline" or the "Company") last three experimental campaigns show successful results in measures of initial cell dose and important time aspects.During the autumn, Cline, as previously communicated, carried out three major experimental campaigns in the StemCART project. These aimed to arrive at a suitable starting dose of chondrocyte cells to initiate a clear regeneration of the cartilage tissue. Cells grown according to Cline's method and matrix were placed within a controlled injury made in cartilage tissue removed from knee joints. The goal was to test various